Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

U.S. Markets for Orthopedic Biomaterials 2008

Published by: iData Research, Inc.

Published: Aug. 1, 2008 - 265 Pages


Table of Contents



EXECUTIVE SUMMARY

1.1 TOTAL ORTHOPEDIC BIOMATERIAL MARKET

1.2 GROWTH FACTOR AND BONE GRAFT SUBSTITUTE MARKET

1.3 MACHINED ALLOGRAFT MARKET

1.4 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

1.5 RESORBABLE FIXATION MARKET

1.6 TENDON GRAFT MARKET

1.7 CARTILAGE REPAIR MARKET

1.8 PLATELET / BONE MARROW CONCENTRATION MARKET

1.9 STEM CELL MARKET

1.10 LEADING COMPETITORS

RESEARCH METHODOLOGY

2.1 RESEARCH SCOPE

2.2 IDATA’S 9-STEP METHODOLOGY

2.2.1 Step 1: Project Initiation & Team Selection

2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research

2.2.3 Step 3: Preparation for Interviews & Survey Design

2.2.4 Step 4: Performing Primary Research

2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates

2.2.6 Step 6: Market Forecasting

2.2.7 Step 7: Identify Strategic Opportunities

2.2.8 Step 8: Final Review and Market Release

2.2.9 Step 9: Customer Feedback and Market Monitoring

OVERVIEW OF ORTHOPEDIC BIOMATERIALS

3.1 INTRODUCTION

3.2 OVERVIEW

3.2.1 Growth Factors

3.2.2 Bone Graft Substitutes

3.2.3 Machined Bone Allografts

3.2.4 Hyaluronic Acid Viscosupplementation

3.2.5 Resorbable Tissue and Bone Fixation devices

3.2.6 Tendon Allografts

3.2.7 Cartilage Repair

3.2.8 Platelet and Bone Marrow Concentration

3.2.9 Stem Cell Therapy

3.3 MARKET FORECAST AND ANALYSIS

3.4 MARKET DRIVERS AND LIMITERS

3.4.1 Market Drivers

3.4.2 Market Limiters

3.5 COMPETITIVE ANALYSIS

3.5.1 Market Share

3.5.2 Market Concentration

3.6 MERGERS AND ACQUISTIONS

GROWTH FACTOR MARKET

4.1 INTRODUCTION

4.1.1 Overview

4.1.2 BMP-2 (Medtronic)

4.1.3 BMP-7 (Stryker)

4.1.4 Potential Complications

4.1.5 Future Indications

4.2 MARKET FORECAST AND ANALYSIS

4.2.1 Total Growth Factor Market

4.3 MARKET DRIVERS AND LIMITERS

4.3.1 Market Drivers

4.3.2 Market Limiters

4.4 COMPETITIVE ANALYSIS

BONE GRAFT SUBSTITUTE MARKET

5.1 INTRODUCTION

5.2 OVERVIEW

5.2.1 Autograft

5.2.2 Non-Proprietary Allograft

5.2.3 Demineralized Bone Matrix (DMB)

5.2.4 Synthetic

5.2.5 Xenografts

5.3 MARKET FORECAST AND ANALYSIS

5.3.1 Total Bone Graft Substitute Market

5.3.2 Standard Allograft Market

5.3.3 DBM Market

5.3.4 Synthetic Bone Graft Substitute Market

5.4 MARKET DRIVERS AND LIMITERS

5.4.1 Allograft Market Drivers

5.4.2 Standard Allograft Market Limiters

5.4.3 DBM Market Drivers

5.4.4 DBM Market Limiters

5.4.5 Synthetic Market Drivers

5.4.6 Synthetic Market Limiters

5.5 COMPETITIVE ANALYSIS

5.5.1 Standard Allografts

5.5.2 DBM

5.5.3 Synthetic Bone Graft Substitutes

5.5.4 Autografts

MACHINED BONE ALLOGRAFT MARKET

6.1 INTRODUCTION

6.2 OVERVIEW

6.3 MARKET FORECAST AND ANALYSIS

6.3.1 Total Machined Bone Allograft Market

6.3.2 ALIF Approach

6.3.3 PLIF Approach

6.3.4 TLIF Approach

6.3.5 Cervical Machined Bone Allografts

6.4 MARKET DRIVERS AND LIMITERS

6.4.1 Market Drivers

6.4.2 Market Limiters

6.5 COMPETITIVE ANALYSIS

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

7.1 INTRODUCTION

7.2 OVERVIEW

7.2.1 Three-Injection Cycle Products

7.2.2 Five-Injection Cycle Products

7.2.3 Single-Injection Cycle Products

7.2.4 Reimbursement

7.3 MARKET FORECAST AND ANALYSIS

7.3.1 Total Viscosupplementation Market

7.3.2 Three- Injection Cycle

7.3.3 Five-Injection Cycle

7.4 MARKET DRIVERS AND LIMITERS

7.4.1 Market Drivers

7.4.2 Market Limiters

7.5 COMPETITIVE ANALYSIS

RESORBABLE FIXATION DEVICES

8.1 INTRODUCTION

8.2 OVERVIEW

8.2.1 Materials

8.2.2 Disadvantages Compared to Metal Fixation

8.2.3 Product Description

8.3 MARKET FORECAST AND ANALYSIS

8.3.1 Total Resorbable Market

8.3.2 Resorbable Shoulder Fixation

8.3.3 Resorbable ACL/PCL Fixation

8.3.4 Resorbable Meniscus fixation Devices

8.3.5 Resorbable Fracture Fixation Devices

8.4 MARKET DRIVERS AND LIMITERS

8.4.1 Market Drivers

8.4.2 Market Limiters

8.5 COMPETITIVE ANALYSIS

TENDON GRAFT MARKET

9.1 INTRODUCTION

9.2 OVERVIEW

9.2.1 Bone-Patellar Tendon-Bone (BTB) Graft, ACL and PCL Surgery

9.2.2 Allografted Tendons

9.2.3 Popularity of the Anterior Tibialis AutoGraft

9.2.4 Ligament and Tendon Synthetic Grafts

9.2.5 Ligament and Tendon Xenografts

9.3 MARKET FORECAST AND ANALYSIS

9.3.1 Total Tendon Graft Market

9.3.2 Monte Carlo Analysis of Units Procured per Donor

9.4 MARKET DRIVERS AND LIMITERS

9.4.1 Market Drivers

9.4.2 Market Limiters

9.5 COMPETITIVE ANALYSIS

CARTILAGE REPAIR MARKET

10.1 INTRODUCTION

10.2 OVERVIEW

10.2.1 Autograft

10.2.2 Autologous Chondrocyte Implantation

10.2.3 Osteoarticular Allografts

10.2.4 Meniscal Allografts

10.2.5 Emerging Technologies

MARKET FORECAST AND ANALYSIS

10.2.6 Total Cartilage Repair Market

10.2.7 Autologous Chondrocyte Implantation

10.2.8 Osteochondral Allograft

10.2.9 Meniscal Grafts

MARKET DRIVERS AND LIMITERS

10.2.10 Market Drivers

10.2.11 Market Limiters

10.3 COMPETITIVE ANALYSIS

PLATELET AND BONE MARROW CONCENTRATION MARKET

11.1 INTRODUCTION

11.2 OVERVIEW

11.2.1 Platelet Rich Plasma

11.2.2 Bone Marrow Aspirate

11.3 MARKET FORECAST AND ANALYSIS

11.3.1 Total Platelet and Bone Marrow Concentration Market

11.3.2 Spinal Platelet Concentration Market

11.3.3 Extremity and Sports Medicine Platelet Concentration

11.3.4 Bone Marrow Aspirate Concentration

11.4 MARKET DRIVERS AND LIMITERS

11.4.1 Market Drivers

11.4.2 Market Limiters

11.5 COMPETITIVE ANALYSIS

ORTHOPEDIC STEM CELL MARKET

12.1 INTRODUCTION

12.2 OVERVIEW

12.2.1 Lineage

12.2.2 Legislation

12.2.3 Other Therapeutic Applications

12.3 MARKET FORECAST AND ANALYSIS

12.3.1 Orthopedic Stem Cells

12.3.2 Monte Carlo Simulation of Hypothetical Stem Cell Market

12.4 MARKET DRIVERS AND LIMITERS

12.4.1 Market Drivers

12.4.2 Market Limiters

12.5 COMPETITIVE ANALYSIS

ABBREVIATIONS

LIST OF FIGURES

EXECUTIVE SUMMARY

RESEARCH METHODOLOGY

OVERVIEW OF ORTHOPEDIC BIOMATERIALS

Figure 3-1 Total Orthopedic Biomaterials Market, U.S., 2004 - 2014

Figure 3-2 Drivers and Limiters, Orthopedic Biomaterials Market, U.S., 2007

Figure 3-3 Leading Competitors, Orthopedic Biomaterials Market, U.S. 2007 (Part 1 of 2)

Figure 3-4 Leading Competitors, Orthopedic Biomaterials Market, U.S. 2007 (Part 2 of 2)

Figure 3-5 Market Concentration, Orthopedic Biomaterials Market, U.S., 2007

GROWTH FACTOR MARKET

Figure 4-1 Total Growth Factor Market, U.S., 2004 - 2014

Figure 4-2 Market Drivers and Limiters, Growth Factor Market, U.S., 2007

Figure 4-3 Leading Competitors, Growth Factor Market, U.S., 2007

BONE GRAFT SUBSTITUTE MARKET

Figure 5-1 Spinal Bone Graft Substitutes Procedure Forecast, U.S., 2004 - 2014 . 52

Figure 5-2 Total Bone Graft Substitute Market, U.S., 2004-2014

Figure 5-3 Total Standard Allograft Market, U.S., 2004-2014

Figure 5-4 Spinal Standard Allograft Market, U.S., 2004-2014

Figure 5-5 Thoracolumbar Standard Allograft Market, U.S., 2004-2014

Figure 5-6 Cervical Standard Allograft Market, U.S., 2004 - 2014

Figure 5-7 Extremity and Craniomaxillofacial Standard Allograft Market, U.S., 2004 - 2014

Figure 5-8 Total DBM Market, U.S., 2004 -2007

Figure 5-9 Spinal DBM Market, U.S., 2004-2007

Figure 5-10 Thoracolumbar DBM Market, U.S., 2004-2014

Figure 5-11 Cervical DBM Market, U.S., 2004-2014

Figure 5-12 Extremity and Craniomaxillofacial DBM Market, U.S., 2004-2014

Figure 5-13 Total Synthetic Bone Graft Substitute Market, U.S., 2004-2014

Figure 5-14 Spinal Synthetic Bone Graft Substitute Market

Figure 5-15 Thoracolumbar Synthetic Bone Graft Substitute Market, U.S., 2004-2014

Figure 5-16 Cervical Synthetic Bone Graft Market, U.S., 2004-2014

Figure 5-17 Extremity and Craniomaxillofacial Synthetic Bone Graft Substitute Market, U.S., 2004-2014

Figure 5-18 Drivers and Limiters, Standard Allograft Market, U.S., 2007

Figure 5-19 Drivers and Limiters, DBM Market, U.S., 2007

Figure 5-20 Driver’s and Limiters, Synthetic Bone Graft Substitute Market, U.S., 2007

Figure 5-21 Leading Competitors, Bone Graft Substitute Market, U.S., 2007

MACHINED BONE ALLOGRAFT MARKET

Figure 6-1 Total Machined Allograft Market, U.S., 2004-2014

Figure 6-2 ALIF, Percentage of Total Machined Bone Allograft Procedures, U.S., 2004-2014

Figure 6-3 ALIF Machined Bone Allograft Market, U.S., 2004-2014

Figure 6-4 PLIF, Percentage of Total Machined Bone Allograft Procedures, U.S., 2004-2014

Figure 6-5 PLIF Machined Bone Allograft Market, U.S., 2004-2014

Figure 6-6 TLIF, Percentage of Total Machined Bone Allograft Procedures, U.S., 2004-2014

Figure 6-7 TLIF Machined Bone Allograft Market, U.S., 2004-2014

Figure 6-8 Cervical, Percentage of Total Machined Bone Allograft Procedures, U.S., 2004-2014

Figure 6-9 Cervical Machined Bone Allograft Market, U.S., 2004-2014

Figure 6-10 Drivers and Limiters, Machined Bone Allograft Market, U.S., 2007 120

Figure 6-11 Leading Competitors, Machined Bone Allograft Market, U.S. 2007 122

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

Figure 7-1 Hyaluronic Acid Viscosupplementation J-Codes, 2007

Figure 7-2 Hyluronic Acid Viscosupplementation Market, U.S., 2004 - 2014

Figure 7-3 Three-Injection Cycle Viscosupplementation Market, U.S., 2004 - 2014

Figure 7-4 Five-Injection Cycle Hyluronic Acid Viscosupplmentation Market, U.S., 2004 - 2014

Figure 7-5 Drivers and Limiters, Hyaluronic Viscosupplementation Market, U.S., 2007

Figure 7-6 Leading Competitors, Hyluronic Acid Viscosupplementation Market, U.S., 2007

RESORBABLE FIXATION DEVICES

Figure 8-1 ACL and PCL Reconstruction Procedures, U.S., 2004 - 2014

Figure 8-2 Total Resorbable Fixation Device Market, U.S., 2004 - 2014

Figure 8-3 Total Resorbable Fixation Device Market by Segment, U.S., 2004 - 2014

Figure 8-4 Resorbable Shoulder Fixation Market, U.S., 2004 - 2014

Figure 8-5 Total ACL/PCL Resorbable Fixation Market, U.S. 2004-2014

Figure 8-6 ACL/PCL Total Resorbable Interference Screw Market, U.S., 2004 - 2014

Figure 8-7 Resorbable Interference Screw Market by Material, U.S., 2004 - 2014

Figure 8-8 ACL/PCL Standard Resorbable Interference Screw Market, U.S., 2004 - 2014

Figure 8-9 ACL/PCL Composite Resorbable Interference Screw Market, U.S., 2004 - 2014

Figure 8-10 ACL/PCL Resorbable Cross Pin Market, U.S., 2004 - 2014

Figure 8-11 Total Resorbable Meniscus Fixation Market, U.S., 2004 - 2014

Figure 8-12 Meniscal Tack Market, U.S., 2004 - 2014

Figure 8-13 Hybrid Tack Market, U.S., 2004 - 2014

Figure 8-14 Resorbable Fracture Fixation Market, U.S., 2004 - 2014

Figure 8-15 Drivers and Limiters, Resorbable Fixation Market, U.S., 2007

Figure 8-16 Leading Competitors, Total Resorbable Fixation Market, U.S., 2007

Figure 8-17 Leading Competitors, Resorbable Shoulder Fixation Market, U.S., 2007

Figure 8-18 Leading Competitors, Resorbable ACL/PCL Fixation Market, U.S., 2007

Figure 8-19 Leading Competitors, Resorbable Meniscus Fixation Market, U.S., 2007

Figure 8-20 Leading Competitors, Resorbable Fracture Fixation, U.S., 2007

TENDON GRAFT MARKET

Figure 9-1 ACL and PCL Reconstruction Procedures, U.S., 2004 - 2014

Figure 9-2 Total Tendon Graft Market, U.S., 2004 - 2014

Figure 9-3 Units procured per Donor, U.S., 2007

Figure 9-4 Market Drivers and Limiters, Tendon Graft Market, U.S., 2007

Figure 9-5 Leading Competitors, Tendon Graft Market, U.S., 2007

CARTILAGE REPAIR MARKET

Figure 10-1 Cartilage Autograft Procedures, U.S., 2004 - 2014

Figure 10-2 Total Cartilage Repair Market, U.S., 2004 - 2014

Figure 10-3 ACI Market, U.S., 2004 - 2014

Figure 10-4 Osteochondral Allograft Market, U.S., 2004 - 2014

Figure 10-5 Meniscal Graft Market, U.S., 2004 - 2014

Figure 10-6 Drivers and Limiters, Cartilage Repair Market, U.S., 2007

Figure 10-7 Leading Competitors, Cartilage Repair Market, U.S., 2007

PLATELET AND BONE MARROW CONCENTRATION MARKET

Figure 11-1 Total Platelet and Bone Marrow Concentration Market, U.S., 2004 - 2014

Figure 11-2 Spinal Platelet Concentration Market, U.S., 2004 - 2104

Figure 11-3 Extremity and Sports Medicine Platelet Concentration, U.S., 2004 - 2014

Figure 11-4 Bone Marrow Aspirate Concentration Market, U.S., 2004 - 2104

Figure 11-5 Drivers and Limiters, Platelet and Bone Marrow Concentration Market, U.S., 2007

Figure 11-6 Leading Competitors, Platelet and Bone Marrow Concentration Market, 2007

ORTHOPEDIC STEM CELL MARKET

Figure 12-1 Orthopedic Stem Cell Market, U.S., 2004 - 2007

Figure 12-2 Hypothetical Stem Cell Market, U.S., 2008 - 2014

Figure 12-3 Drivers and Limiters, Orthopedic Stem Cell Market, U.S., 2007

ABBREVIATIONS

LIST OF CHARTS

EXECUTIVE SUMMARY

Chart 1-1 Total Orthopedic Biomaterials Market, U.S. 2007

Chart 1-2 Growth Factor and Bone Graft Substitute Markets, U.S., 2004 - 2014

Chart 1-3 Machined Bone Allograft Market, U.S., 2004 - 2014

Chart 1-4 Resorbable Fixation Market, U.S., 2007

Chart 1-5 Tendon Allograft Unit Volumes in Relation to ACL/PCL Procedures, U.S., 2004 - 2014

Chart 1-6 Cartilage Repair Market, U.S., 2004 - 2014

Chart 1-7 Platelet Concentration Market Growth Rate, 2004 - 2007

Chart 1-8 Potential Value of Future Stem Cell Market Entrants, Cumulative Market Value, U.S. 2008 - 2014

Chart 1-9 leading Competitors, Orthopedic Biomaterials Market, U.S., 2007

RESEARCH METHODOLOGY

OVERVIEW OF ORTHOPEDIC BIOMATERIALS

Chart 3-1 Total Orthopedic Biomaterials Market, U.S., 2004 - 2014

Chart 3-2 Total Orthopedic Biomaterials Market by Segment, U.S., 2007 - 2014

Chart 3-3 Total Orthopedic Biomaterials Market by Segment, U.S., 2007

Chart 3-4 Total Orthopedic Biomaterials Market by Segment, U.S., 2014

Chart 3-5 Leading Competitors, Orthopedic Biomaterials Market, U.S., 2007

Chart 3-6 Market Concentration, Orthopedic Biomaterials Market, U.S., 2007

GROWTH FACTOR MARKET

Chart 4-1 Total Growth Factor Market, U.S., 2004 - 2014

Chart 4-2 Leading Competitors, Growth Factor Market, U.S., 2007

BONE GRAFT SUBSTITUTE MARKET

Chart 5-1 Total Bone Graft Substitute Market, U.S., 2004 - 2014

Chart 5-2 Total Standard Allograft Market, U.S., 2004 - 2014

Chart 5-3 Standard Spine Allograft Market, U.S., 2004 - 2014

Chart 5-4 Thoracolumbar Standard Allograft Market, U.S., 2004 - 2014

Chart 5-5 Cervical Standard Allograft Market, U.S., 2004 - 2014

Chart 5-6 Extremity and CMF Standard Allograft Procedures, U.S., 2007

Chart 5-7 Extremity and Craniomaxillofacial Standard Allograft Market, U.S., 2004 - 2014

Chart 5-8 Total DBM Market, U.S., 2004 - 2007

Chart 5-9 Spinal DBM Market, U.S., 2004 - 2007

Chart 5-10 Thoracolumbar DBM Market, U.S., 2004 - 2014

Chart 5-11 Cervical DBM Market, U.S., 2004 - 2014

Chart 5-12 Extremity and CMF DBM Procedures, U.S., 2007

Chart 5-13 Extremity and Craniomaxillofacial DBM Market, U.S., 2004 - 2014

Chart 5-14 Total Synthetic Bone Graft Substitute Market, U.S., 2004 - 2014

Chart 5-15 Spinal Synthetic Bone Graft Substitute Market

Chart 5-16 Thoracolumbar Synthetic Bone Graft Substitute Market, U.S., 2004 - 2014

Chart 5-17 Cervical Synthetic Bone Graft Market, U.S., 2004 - 2014

Chart 5-18 Extremity and CMF Synthetic Bone Graft Substitute Procedures, U.S., 2007

Chart 5-19 Extremity and Craniomaxillofacial Synthetic Bone Graft Substitute Market, U.S., 2004 - 2014

Chart 5-20 Leading Competitors for Standard Allograft Market, U.S., 2007

Chart 5-21 Leading Competitors for DBM Market, U.S., 2007

Chart 5-22 Leading Competitors for Synthetic Bone Graft Substitutes, U.S., 2007

MACHINED BONE ALLOGRAFT MARKET

Chart 6-1 Machined Allograft Market, U.S., 2004 - 2014

Chart 6-2 ALIF Machined Bone Allograft Market, U.S., 2004 - 2014

Chart 6-3 PLIF Machined Bone Allograft Market, U.S., 2004 - 2014

Chart 6-4 TLIF Machined Bone Allograft Market, U.S., 2004 - 2014

Chart 6-5 Cervical Machined Bone Allograft Market, U.S., 2004 - 2014

Chart 6-6 Leading Competitors, Machined Bone Allograft Market, U.S. 2007

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

Chart 7-1 Hyluronic Acid Viscosupplementation Market, U.S., 2004 - 2014

Chart 7-2 Three-Injection Cycle Viscosupplementation Market, U.S., 2004 - 2014

Chart 7-3 Five-Injection Cycle Hyluronic Acid Viscosupplmentation Market, U.S., 2004 - 2014

Chart 7-4 Leading Competitors, Hyaluronic Acid Viscosupplementation Market, U.S., 2007

RESORBABLE FIXATION DEVICES

Chart 8-1 Total Resorbable Fixation Device Market, U.S., 2004 - 2014

Chart 8-2 Total Resorbable Fixation Device Market by Segment, U.S., 2004 - 2014

Chart 8-3 Resorbable Shoulder Fixation Market, U.S., 2004 - 2014

Chart 8-4 Total ACL/PCL Resorbable Fixation Market, U.S. 2004 - 2014

Chart 8-5 ACL/PCL Total Resorbable Interference Screw Market, U.S., 2004 - 2014

Chart 8-6 ACL/PCL Standard Resorbable Interference Screw Market, U.S., 2004 - 2014

Chart 8-7 ACL/PCL Composite Resorbable Interference Screw Market, U.S., 2004 - 2014

Chart 8-8 ACL/PCL Resorbable Cross Pin Market, U.S., 2004 - 2014

Chart 8-9 Total Resorbable Meniscus Fixation Market, U.S., 2004 - 2014

Chart 8-10 Meniscal Tack Market, U.S., 2004 - 2014

Chart 8-11 Hybrid Tack Market, U.S., 2004 - 2014

Chart 8-12 Resorbable Fracture Fixation Market, U.S., 2004 - 2014

Chart 8-13 Leading Competitors, Resorbable Fixation Market, U.S., 2007

TENDON GRAFT MARKET

Chart 9-1 Total Tendon Graft Market, U.S., 2004 - 2014

Chart 9-2 Units procured per Donor, U.S., 2007

Chart 9-3 Leading Competitors, Tendon Graft Market, U.S., 2007

CARTILAGE REPAIR MARKET

Chart 10-1 Total Cartilage Repair Market, U.S., 2004 - 2014

Chart 10-2 ACI Market, U.S., 2004 - 2014

Chart 10-3 Osteochondral Allograft Market, U.S., 2004 - 2014

Chart 10-4 Meniscal Graft Market, U.S., 2004 - 2014

Chart 10-5 Leading Competitors, Total Cartilage Repair Market, U.S., 2007

Chart 10-6 Leading Competitors, Cartilage Allograft Market, U.S., 2007

PLATELET AND BONE MARROW CONCENTRATION MARKET

Chart 11-1 Total Platelet and Bone Marrow Concentration Market, U.S., 2004 - 2014

Chart 11-2 Spinal Platelet Concentration Market, U.S., 2004 - 2014

Chart 11-3 Extremity and Sports Medicine Platelet Concentration, U.S., 2004 - 2014

Chart 11-4 Bone Marrow Aspirate Concentration, U.S., 2004 - 2104

Chart 11-5 Leading Competitors, Platelet and Bone Marrow Concentration Market, 2007

ORTHOPEDIC STEM CELL MARKET

Chart 12-1 Orthopedic Stem Cell Market, U.S., 2004 - 2007

Chart 12-2 Hypothetical Stem Cell Market, 2008 - 2014

ABBREVIATIONS

Abstract

In 2007, the orthopedic biomaterials market was valued at over $2.6 billion, growing at an associated CAGR of 12.9% by 2014.There is great promise in the future performance of the orthopedic biomaterials market. To date there has been a multitude of products introduced to the market, with some becoming spectacular successes. Future growth for this market will be a result of continued improvements in product technology to meet the needs of patients. This comprehensive report covers a number of disciplines, including spinal surgery, sports medicine, tissue donation and biotechnology. In each segment of this report, current market conditions are examined. Furthermore, the behavior of each sub-segment over the forecast period is examined in depth.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report

Price and Delivery Options
See related reports or call the number above for help from a research specialist.


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009